Home
News

News

All News
By Year:
2019
2018
2017
2016

Nov 12, 2018

DiaMedica Therapeutics Has Applied to List its Common Shares on Nasdaq, Announces Share Consolidation

Nov 6, 2018

DiaMedica Therapeutics Announces Results From Annual General and Special Meeting of Shareholders

Sep 27, 2018

DiaMedica Therapeutics and Ahon Pharma, a Fosun Pharma Portfolio Company, Announces Signing of License Agreement for DM199 in China for Acute Ischemic Stroke

Sep 5, 2018

DiaMedica Therapeutics Announces the Appointment of Dr. Harry Alcorn Jr. as Chief Medical Officer

May 3, 2018

DiaMedica Announces Positive Results From FDA Meeting on Planned Clinical Trial in Patients with Chronic Kidney Disease

Apr 5, 2018

DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer

Apr 4, 2018

DiaMedica to Present at the MicroCap Conference on April 10th in New York City at the Essex House

Mar 29, 2018

DiaMedica Therapeutics Announces Final Closing of Private Placement

Mar 20, 2018

DiaMedica Therapeutics Announces Closing of Private Placement

Feb 22, 2018

DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke